Centogene and Anylam launch clinical progr...Diagnostics developer Centogene NV and Alnylam Pharmaceuticals launched a clinical programme aimed at improving ATTRv diagnosis. more ➔
Avantium NV bags money for demo plantGreen chemistry company Avantium NV has secured a €7.5m funding from the National Programme Groningen to support the construction of a 5 kilotonnes FDCA plant. more ➔
How stress brings cancer to life againStress hormones such as cortisol or norephidrine can reawaken dormant tumour cells, a research team led by AstraZeneca has found out. more ➔
UK approves Biontech/Pfizer Covid-19 vacci...Biontech and Pfizer have received emergency approval for their COVID-19 vaccine in the UK. Mass immunization could start next week, the first in Western countries. more ➔
UK approves Biontech/Pfizer Covid-19 vacci...Biontech and Pfizer have received emergency approval for their COVID-19 vaccine in the UK. Mass immunization could start next week, the first in Western countries. more ➔
Swiss Noema Pharma raises CHF54m in Series...Noema Pharma AG kicks off with CHF54m and licenced drug candidates from Roche AG. more ➔
Germany first EU country to launch COVID-1...After months of lobbying by the BIOM biotech cluster, Bavaria is launching a €50m initiative to push the best and fastest COVID-19 therapies. more ➔
Moderna to file for EU approval of mRNA-12...COVID-19 mRNA vaccine developer Moderna Inc reported it will file for FDA and EMA authorisation of mRNA-1273 based on Phase III results. more ➔
Drug set to rescue COVID-19 patients at IC...Aviptadil, a vasodilator originally developed to treat erectile dysfunction, led to a 72% survival in critically-ill COVID-19 patients. more ➔
Rapid antibody development to cure COVID-1...In addition to vaccination programmes, the SARS-CoV-2 pandemic requires safe and efficient treatment options for patients infected and suffering from Covid-19 disease. Virus-neutralising antibody therapeutics … more ➔
